Source: Markets Insider

Micro Interventional Devices, Inc.: FDA Grants Micro Interventional Devices, Inc. Breakthrough Device Designation for the MIA -T Percutaneous Tricuspid Annuloplasty System

NEWTOWN, Pa., May 27, 2021 /PRNewswire/ -- Micro Interventional Devices (MID) has received Breakthrough Device Designation from the U.S. Food and ...

Read full article »
Micro Interventional Devices, Inc.'s Competitors | Micro Interventional Devices, Inc.'s News | Micro Interventional Devices, Inc.'s Financials
Stay up-to-date with the latest news on MID
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Michael P. Whitman's photo - President & CEO of MID

President & CEO

Michael P. Whitman

CEO Approval Rating

91/100

Read more
Stay up-to-date with the latest news on MID